Finally, in vitro experiments demonstrated that IL-17 functioned as an oncogene by inhibiting the apoptosis of LC cells via the PI3K/AKT/FAS/FASL pathways. This evidence concerns the gene AKT1 and laryngotracheoesophageal cleft.